Products for Research Use Only
RegisterLogin

CK2α-IN-1

CAT: 0804-HY-148318-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-148318-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CK2α-IN-1 (compound 2) is a selective CK2α inhibitor (IC50=7.0 µM; Ki=1.6 µM) that exhibits a non-ATP-competitive mode of action. CK2α-IN-1 exhibits good potential for anticancer studies[1].
CAS Number
443747-52-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Casein Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ck2α-in-1.html
Purity
98.34
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC(NC2=NC(C3=CC([N+]([O-])=O)=CC=C3)=CS2)=CC=C1)O
Molecular Formula
C16H11N3O4S
Molecular Weight
341.34
Precautions
H302, H315, H319
References & Citations
[1]Bestgen B, et al. 2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site. J Med Chem. 2019 Feb 28;62 (4) :1803-1816.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-135816CK2/PIM1-IN-1
HY-135906-01CK2/ERK8-IN-1
HY-139004-01SGC-CK2-1
HY-168517PIM-1/CK2-IN-2
HY-151382CK2-IN-3
HY-153788-01CK2-IN-7
HY-148328-01CK2-IN-4
HY-174350CK2-IN-15
HY-148763CK2-IN-6
HY-158369-01CK2-IN-10

Alternative Products

CatalogName
UA080063-01CK2α1/CK2β Protein
T73269-01CK2α-IN-1
T23090-01CK2-IN-1
BA3733-5SGC-CK2-1
GTR19234032-01HDAC/CK2-IN-1
GTR19206208-01CK2/PIM1-IN-1
GTR19184618-01BRD4/CK2-IN-1
7450/50SGC CK2-1
GTR19206209-01CK2/ERK8-IN-1
M33895-01CK2-IN-1 B

Popular Products